To this point, no study in ARDS patients has specifically investigated the impact of ECMO on EPC- and MSC mobilization in interaction with potential mobilizing factors like vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang2). Here, ANGPT2 is linked to acute respiratory distress syndrome.